Comparison

BML-259 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 50 mg
Item no. HY-108348-50mg
CASRN 267654-00-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
BML-259 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor, with IC50s of 64 and 98 nM for Cdk5 and Cdk2, respectively[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
Molecular Weight
260.35
Clinical Information
No Development Reported
Solubility
DMSO : 125 mg/mL (ultrasonic)
Pathway
Cell Cycle/DNA Damage
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close